体重管理药物停用后的体重反弹:系统综述与Meta分析
该系统综述与Meta分析纳入37项研究(63个干预组,9341名参与者),评估超重或肥胖成人停用体重管理药物后的体重反弹速率。结果显示平均每月体重反弹0.4 kg(95%CI 0.3至0.5),且所有心血管代谢指标预计在停药后1.4年内回到基线;药物停用后的反弹速度快于行为体重管理项目(每月多0.3 kg,95%CI 0.22至0.34)。
要点
- 停用体重管理药物后平均每月体重反弹0.4 kg(95%CI 0.3至0.5)。
- 心血管代谢指标预计在停药后1.4年内回到基线。
- 药物停用后体重反弹比行为体重管理项目停止后快每月0.3 kg(95%CI 0.22至0.34)。
核心结论
- 停用体重管理药物后体重快速反弹,心血管代谢指标的有益效应逆转。
- 药物停用后的体重反弹速度快于行为体重管理项目停止后。
- 这些发现提示在缺乏更全面的体重管理方案时,短期使用这些药物需谨慎。
研究设计与样本
- 系统综述与Meta分析,检索从建库至2025年2月的试验注册库和数据库(Medline、Embase、PsycINFO、CINAHL、Cochrane、Web of Science及试验注册库)。
- 纳入标准为体重管理药物使用≥8周且在停药后随访≥4周的随机对照试验、非随机试验和观察性研究,对象为超重或肥胖成人。
- 对照为任何非药物减重干预或安慰剂。
- 共筛选9288条标题,最终纳入37项研究(63个干预组,9341名参与者)。
- 平均治疗时长39周(范围11-176周),平均随访32周(范围4-104周)。
主要发现
- 停药后平均每月体重反弹0.4 kg(95%CI 0.3至0.5);在随机对照试验中混合模型显示每月0.3 kg(95%CI 0.2至0.4)对比对照。
- 所有心血管代谢指标预计在停用体重管理药物后1.4年内回到基线。
- 体重管理药物停用后的体重反弹比行为体重管理项目停止后快每月0.3 kg(95%CI 0.22至0.34),且独立于初始体重下降。
- 敏感度分析中估计值和精确度稳健。
临床怎么用
- 作者认为,这些发现提示在缺乏更全面的体重管理方案时,短期使用体重管理药物需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To quantify and compare the rate of weight regain after cessation of weight management medications (WMMs) in adults with overweight or obesity. DESIGN: Systematic review and meta-analysis. STUDY SELECTION: Trial registries and databases (Medline, Embase, PsycINFO, CINAHL, Cochrane, Web of Science, and trial registries) were searched from inception until February 2025 for randomised controlled trials (RCTs), non-randomised trials, and observational studies that included WMM (≥8 weeks) with follow-up for ≥4 weeks after cessation of treatment in adults with overweight or obesity. Comparators were any non-drug weight loss intervention or placebo. DATA EXTRACTION AND SYNTHESIS: The review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Two independent reviewers screened titles, extracted data, and assessed the risk of bias using the Cochrane Risk of Bias 2 tool for RCTs and the ROBINS-I tool for non-randomised trials. Data were analysed using mixed effect, meta-regression, and time-to-event models. Weight regain after cessation of WMM was compared with that reported after cessation of behavioural weight management programmes (BWMPs). MAIN OUTCOME MEASURES: The primary outcome was rate of weight regain from end of treatment, with associated changes in cardiometabolic markers as a secondary outcome. RESULTS: Of the 9288 titles screened, 37 studies (63 intervention arms, 9341 participants) were included. Average treatment duration was 39 (range 11-176) weeks, with average follow-up of 32 (4-104) weeks. The average monthly rate of weight regain was 0.4 kg (95% confidence interval (CI) 0.3 to 0.5) (mixed model 0.3 kg (0.2 to 0.4) monthly v control in RCTs). All cardiometabolic markers were projected to return to baseline within 1.4 years after the cessation of WMM. Weight regain was faster after WMM than after BWMP (by 0.3 kg (0.22 to 0.34) monthly), independent of initial weight loss. Estimates and precision were robust in sensitivity analyses. CONCLUSIONS: This review found that cessation of WMM is followed by rapid weight regain and reversal of beneficial effects on cardiometabolic markers. Regain after WMM was faster than after BWMP. These findings suggest caution in short term use of these drugs without a more comprehensive approach to weight management. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42024532069.
引用
- West S, Scragg J, Aveyard P, et al. Weight regain after cessation of medication for weight management: systematic review and meta-analysis. BMJ. 2026. PMID: 41500720. doi:10.1136/bmj-2025-085304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。